|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q58619957
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010723.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q58619957
|
|
024
|
|
|
‡a
0000-0003-0159-0375
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q58619957
|
|
100
|
0 |
|
‡a
Elisabeth Esteban
‡c
researcher ORCID ID = 0000-0003-0159-0375
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Elisabeth Esteban
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Glutamine effects on heat shock protein 70 and interleukines 6 and 10: Randomized trial of glutamine supplementation versus standard parenteral nutrition in critically ill children
|
|
670
|
|
|
‡a
Author's Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge
|
|
670
|
|
|
‡a
Author's Kinetics of Procalcitonin in Pediatric Patients on Extracorporeal Membrane Oxygenation
|
|
670
|
|
|
‡a
Author's Morbidity and mortality risk factors of pertussis in pediatrics
|
|
670
|
|
|
‡a
Author's Sex differences in children with severe health conditions: Causes of admission and mortality in a Pediatric Intensive Care Unit
|
|
670
|
|
|
‡a
Author's The impact of a quality improvement intervention to reduce nosocomial infections in a PICU.
|
|
909
|
|
|
‡a
(orcid) 0000000301590375
‡9
1
|
|
919
|
|
|
‡a
impactofaqualityimprovementinterventiontoreducenosocomialinfectionsinapicu
‡A
The impact of a quality improvement intervention to reduce nosocomial infections in a PICU.
‡9
1
|
|
919
|
|
|
‡a
glutamineeffectsonheatshockprotein70andinterleukines6and10randomizedtrialofglutaminesupplementationversusstandardparenteralnutritionincriticallyillchildren
‡A
Glutamine effects on heat shock protein 70 and interleukines 6 and 10: Randomized trial of glutamine supplementation versus standard parenteral nutrition in critically ill children
‡9
1
|
|
919
|
|
|
‡a
immunomodulationinsepsistheroleofendotoxinremovalbypolymyxinbimmobilizedcartridge
‡A
Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge
‡9
1
|
|
919
|
|
|
‡a
kineticsofprocalcitonininpediatricpatientsonextracorporealmembraneoxygenation
‡A
Kinetics of Procalcitonin in Pediatric Patients on Extracorporeal Membrane Oxygenation
‡9
1
|
|
919
|
|
|
‡a
morbidityandmortalityriskfactorsofpertussisinpediatrics
‡A
Morbidity and mortality risk factors of pertussis in pediatrics
‡9
1
|
|
919
|
|
|
‡a
sexdifferencesinchildrenwithseverehealthconditionscausesofadmissionandmortalityinapediatricintensivecareunit
‡A
Sex differences in children with severe health conditions: Causes of admission and mortality in a Pediatric Intensive Care Unit
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
BNE|XX1016200
|
|
996
|
|
|
‡2
BNE|XX973688
|
|
996
|
|
|
‡2
BAV|495_147828
|
|
996
|
|
|
‡2
DNB|1194679102
|
|
996
|
|
|
‡2
SUDOC|079829015
|
|
996
|
|
|
‡2
BNE|XX1718837
|
|
996
|
|
|
‡2
ISNI|0000000059215533
|
|
996
|
|
|
‡2
RERO|A025098177
|
|
996
|
|
|
‡2
BNE|XX6128935
|
|
996
|
|
|
‡2
BNF|16907688
|
|
996
|
|
|
‡2
LC|no2011194248
|
|
996
|
|
|
‡2
PLWABN|9813664410105606
|
|
996
|
|
|
‡2
SUDOC|235245909
|
|
996
|
|
|
‡2
BNC|981058516525506706
|
|
996
|
|
|
‡2
LC|nb2023010803
|
|
996
|
|
|
‡2
ISNI|0000000116039370
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
